MEMBERS
PROVIDERS
ABOUT

Nurse Hotline

888-516-6166

GET A RIDE

DECEMBER 2025

Connection Newsletter

Must-know policy changes, new guidelines, and programs affecting your patients.

Practice Tactics

2026 Prior Authorization Timeline Changes

Beginning Jan. 1, 2026, turnaround timelines for standard medical and behavioral health prior authorization requests will decrease to seven days. A 14-day extension may be applied when additional information is needed to complete the determination. These changes are designed to support timely access to care while ensuring appropriate clinical review.

HRSN Benefit and Process Changes for 2026

Beginning Jan. 1, 2026, several updates will take effect for Health-Related Social Needs (HRSN) benefits. These changes adjust timelines, benefit names, application requirements, and clinical eligibility. The goal is to ensure members with the highest needs receive timely support.

Turnaround Timelines

The standard processing time will decrease to seven days. A 14-day extension may be approved when additional documentation is required.

Benefit Name Changes

To improve clarity for members and providers, HRSN benefits will receive updated names:

  • HRSN Climate will be renamed Home Changes for Health.
  • HRSN Home Modifications/Remediations will be renamed Home Changes for Safety.

Application Requirements

Requests for rent or utility support must include:

  • Completed application forms
  • Income verification for all adults in the household
  • A signed lease agreement

Incomplete requests will be dismissed, and members will be notified.

Eligibility Requirements

Applications will no longer be accepted by fax. Submissions may be delivered by email or in person.

Clinical eligibility criteria will be tightened to prioritize members with the greatest needs.

Advance Directives: OAR Requirements and UHA Policy

Providers must follow Oregon Administrative Rules (OARs) and UHA policy to consistently collect, document, upload, and share advance directives. At each new encounter and at regular intervals, providers must confirm whether a patient has an advance directive, store the most current version in the EHR, and ensure that it follows the patient during transitions in care. Valid directives must be honored or, if a provider cannot comply, the patient must be transferred without delay.

OAR Requirements for Advance Directives

Offer Written Information
Providers must offer written advance directive information to adult patients and document whether the patient accepts or declines the materials.

Document Status in the Medical Record
The medical record must reflect one of the following:

  • A completed advance directive
  • A documented refusal
  • A note that materials were offered
  • A request for more information

Honor Valid Directives
Providers must follow valid directives unless a legal exception applies. If unable to comply for ethical, policy, or personal reasons, the provider must arrange a timely transfer or reassignment.

Share Information During Transitions
When patients are admitted, transferred, or discharged, providers must share the most recent advance directive or document that no directive is available.

UHA Policy Expectations for Care Coordination

Ask, Document, and Upload
Providers should ask about advance directive status at each new patient encounter and at regular intervals. Copies must be uploaded to the EHR in a location accessible to the entire care team.

Support Patient Understanding
Providers should explain advance directives in simple language and allow time for questions. The intent is to support informed, unpressured decision-making.

Coordinate Across Settings
The most current directive must accompany the patient during transfers, admissions, discharges, or referrals to prevent gaps in communication.

Resolve Conflicts Promptly
If a directive conflicts with the proposed treatment plan, providers should communicate quickly with the patient or surrogate. Care coordination or case management teams may be consulted to resolve concerns.

Promote Consistency and Respect
Advance directives are essential clinical documents. All UHA-contracted providers should know where they are stored in the EHR, how to verify them, and how to follow them.

Workflow Best Practices for Providers

  • Ask early and revisit the discussion during major health changes.
  • Keep copies updated, legible, and easy to access.
  • Clearly flag changes or updates in the record.
  • Involve care coordination when situations are unclear.
  • Encourage patients to review directives with family or chosen decision-makers.

Why Advance Directives Matter

Advance directives help ensure that patients receive care that reflects their values and priorities when they cannot communicate their wishes. They reduce confusion, prevent unwanted treatment, and support smooth communication between clinics, hospitals, long-term care facilities, and behavioral health partners.

UHA care coordination staff can assist with patient questions or transition planning. Updated templates and patient handouts are available upon request.

Support and Resources

Phone: 541-229-4842
Email: casemanagement@umpquahealth.com

2025–2026 Benefit Plan Updates

Several benefit plan changes will take effect between November 2025 and January 2026. These updates include code additions, code terminations, and revised prior authorization requirements for specific services.

Effective Nov. 24, 2025

J0736 – Injection, clindamycin phosphate, 300 mg
Prior authorization is no longer required for any provider.

J0737
Prior authorization is no longer required for any provider.

S0077 – Injection, clindamycin phosphate, 300 mg
This code has been removed from the benefit plan because it was terminated on June 30, 2023, according to HCPCData.com.

Effective Dec. 1, 2025

97151 – Behavior Identification Assessment
No prior authorization required.

H0020 – Alcohol and/or Drug Services; Methadone Administration and/or Service
No prior authorization required.

Effective Jan. 1, 2025

PT/OT/ST Visit Limits
Beginning Jan. 1:

  • Non-EPSDT members may receive 8 visits per calendar year without prior authorization (in network, with above-the-line diagnosis).
  • EPSDT members may continue to receive 30 visits per calendar year (in network, with above-the-line diagnosis).
  • All below-the-line diagnoses and out-of-network providers require prior authorization.

THW Connections Corner

2025 THW Program Progress and 2026 Goals

CY2025 marked major progress for the Traditional Health Worker (THW) Program in Douglas County. UHA expanded THW capacity across all worker types, with the greatest growth in community-based settings. The program strengthened local partnerships, increased utilization, and built the foundation for continued advancement in CY2026.

Key Accomplishments in CY2025

  • Launched the Health System Learning Collaborative.
  • Established the Douglas County THW Advisory Group.
  • Developed and distributed the THW Integration and Utilization (I&U) Survey.
  • Expanded the THW network through foundational training and use of the legacy clause.
  • Increased THW utilization in community-based settings.
  • Improved communication through newsletter contributions and the creation of a THW-specific newsletter.
  • Formed a community workgroup to develop foundational training curriculum

Goals for CY2026

  • Strengthen community-building efforts within the THW provider network.
  • Implement a THW satisfaction survey for members.
  • Explore value-based initiatives that connect THW work to quality measures.
  • Improve response rates for the THW I&U survey.
  • Explore contracting and payment models that better support community-based THWs.
  • Develop and submit the THW foundational curriculum to OHA for approval.
  • Continue CY2025 initiatives, including the THW Advisory Group and the Health System Learning Collaborative.

CME for Thee

Winter 2026 Oregon ECHO Programs

The Oregon ECHO Network offers interactive, case-based education for healthcare professionals across the state, using the “All Teach, All Learn” model to build clinical skills and community connection. Programs are offered at no cost and include free continuing medical education (CME) credits.

Why Participate

The ECHO model helps providers:

  • Improve care for patients with complex conditions
  • Earn no-cost CME credits
  • Build community with peers across Oregon
  • Receive support and guidance on challenging cases

Winter 2026 ECHO Programs

  • Adult Mental Health II
  • Autism and ADHD in Adults
  • Social Needs
  • Pharmacological Weight Management in Primary Care
  • Alzheimer’s and Beyond: Advancing Dementia Care
  • Palliative Care in Primary Care
  • Chronic Pain and Opioids
  • Foundations of SUD Care II
  • Substance Use Disorder Prevention and Early Intervention
  • Substance Use Disorders in Emergency Departments
  • Pain Management and SUD in Dental Settings

Communities of Practice (ongoing):

  • Psychiatry
  • Hepatitis C
  • Addiction Medicine

Register Now

Providers can pre-register or learn more:

OHA Health Care Interpreter Rule Changes

The Oregon Health Authority’s Health Care Interpreter Program will host a one-hour webinar on January 15, 2026, to review recent rule changes, available resources, and updates to the statewide interpreter registry. The session includes a panel discussion featuring health care providers and certified health care interpreters.

This webinar is designed for health care providers who work on language access, interpreter coordination, or compliance with interpreter service standards.

Event Details

Date: January 15, 2026
Time: 7:30–8:30 a.m. PT
Format:
Virtual (Zoom)
Registration:

Hosted by: OHA Health Care Interpreter Program

Program Contacts

For questions about the webinar or the OHA Health Care Interpreter Program, contact:

Clinical Corner

New Guidelines for Evaluating and Managing Gastroparesis

The American Gastroenterological Association (AGA) has issued updated, conditional recommendations for evaluating and managing gastroparesis. This summary highlights key diagnostic and treatment guidance based on low- and very-low-certainty evidence.

Background

Gastroparesis is characterized by nausea, vomiting, early satiety, and delayed gastric emptying. Symptoms may overlap with other gastrointestinal disorders, and treatment options remain limited. The new AGA guideline provides clinicians with practical recommendations to standardize evaluation and management.

Key Evaluation Recommendations

  • Rule out mechanical obstruction with upper endoscopy.
  • Use a 4-hour gastric emptying study as the preferred diagnostic test.
  • Avoid 2-hour gastric emptying studies, which are less accurate.
  • Review the medication list for agents that impair gastrointestinal motility.
  • Consider as-needed antiemetics for symptom control.
  • Optimize glycemic control in patients with diabetes mellitus.

First-Line Pharmacologic Treatment

The guideline supports two first-line medications and provides practical prescribing guidance. All recommendations are conditional and based on low or very low certainty.

Metoclopramide

  • Can be used as first-line pharmacologic treatment.
  • Discuss possible adverse effects, including tardive dyskinesia.
  • Evaluate effectiveness at 4- to 8-week intervals.
  • Attempt drug holidays every 8 to 12 weeks when possible.

Erythromycin

  • May also be used as a first-line treatment.
  • Prescribe liquid formulations (40–150 mg orally before meals).
  • Avoid tablet formulations, which are only available in higher doses.
  • Because tachyphylaxis is common, consider drug holidays such as 3 weeks on and 1 week off.

The guideline advises against the routine first-line use of the following agents, although they may be appropriate in select clinical scenarios:

  • Domperidone
  • Prucalopride
  • Aprepitant
  • Nortriptyline
  • Buspirone
  • Cannabidiol

This summary is based on:

  • Staller K et al. AGA clinical practice guideline on management of gastroparesis.
    Gastroenterology. 2025 Oct;169:828.
  • Brett MS. New Guidelines for Evaluating and Managing Gastroparesis, summarizing Staller K et al. in Gastroenterology, October 2025.

Advanced Illness Care Through Housecall Providers

Umpqua Health is partnering with Housecall Providers to offer enhanced support for members living with serious or advanced illnesses. This service complements the care members already receive from their primary care and specialty teams.

Housecall Providers is a nonprofit health organization with nearly 30 years of experience delivering in-home medical care to individuals who are medically complex, homebound, or unable to access traditional care settings.

About the Advanced Illness Care Program

The Advanced Illness Care (AIC) program provides specialized, person-centered support to help members manage complex health conditions. The program focuses on reducing symptom burden, improving comfort, and helping patients maintain the highest possible quality of life.

Eligible members may receive home visits or phone consultations at no cost. The AIC team works closely with the member’s existing providers to ensure communication, coordination, and alignment with the individual’s goals of care.

Care Team

The multidisciplinary AIC team includes:

  • Nurses
  • Social workers
  • Community health workers
  • Spiritual counselors

This team-based approach addresses clinical, emotional, practical, and spiritual needs that commonly arise with advanced illness.

What the Program Offers

Members enrolled in the AIC program may receive:

  • Pain and symptom management
  • Guidance on disease progression, medications, and treatment options
  • Counseling and emotional support
  • Care coordination with the member’s PCP and specialists
  • Support that may reduce emergency department utilization
  • Assistance identifying resources for patients and caregivers

The program does not replace existing care. It adds an additional layer of support for members and families who need it most.

Eligible Conditions

AIC is appropriate for members with serious or progressive illnesses, including:

  • Cancer
  • Heart disease
  • Liver or kidney disease
  • Chronic lung disease (such as COPD)
  • Neurologic disorders (such as Parkinson’s disease or ALS)
  • Immune-related conditions (such as HIV/AIDS)
  • Other chronic or advanced conditions

How to Refer

Providers may refer members by submitting an Advanced Illness Care Referral Form.

Learn more at: Umpqua Health Palliative Care Services

Community Announcements

No announcements this month.

Network News

Umpqua Health Alliance Network Changes

Termed Providers

The following providers have been removed from the Umpqua Health Alliance network:

Provider NameFacilityTermination Date
Gordon Hodges, CSWAAdapt Integrated Health10/24/2025
Caitlin Van Wagenen, CSWAAdapt dba Compass Behavioral Health11/05/2025
Lori Hart, PMHNPCentennial Medical Group10/22/2025
Lorraine Matice, CHWCentennial Medical Group10/03/2025
Malori Dixon, LPCAdapt Integrated Health11/04/2025
Jeremy Holst, QHMA-IAdapt Integrated Health11/06/2025
Linda Deacon, MDPeaceHealth10/29/2025
Yanting Rambow, CRNAPeaceHealth11/07/2025
Sonya Byrd, QMHPAdapt Integrated Health11/14/2025
Michael Rodgers, CRMAdapt Integrated Health11/10/2025
Nathan Hamm, DMDHamm Dentistry, LLC08/10/2024
Mark Hamm, DMDHamm Dentistry, LLC08/10/2024

New Providers

The following providers have joined the Umpqua Health Alliance network:

Provider NameFacilityEffective Date
Judy Black, MDEvergreen Family Medicine07/14/2025
Matthew Stark, PACEvergreen Family Medicine03/04/2025
Ethan Burdman, PACPeaceHealth10/27/2025
Tiffany Cordova, LCSWPeaceHealth10/27/2025
Ashley Sweeney, NPPeaceHealth10/17/2025
Judy Gabehart-Geant, LPCAdapt Integrated Health11/11/2025
Amber Gray, LPCAdapt Integrated Health11/17/2025
Kira Lathrop, LPCAdapt Integrated Health11/11/2025
Katrina West, PCAAdapt Integrated Health02/12/2025
Rachel Ochoa, RN, QMHA-RAdapt Integrated Health11/13/2025
Rachael Fowler, QMHP-RAdapt Integrated Health09/15/2025
Kelsea Knee, QMHA-RAdapt Integrated Health10/13/2025
Megan Locker, QHMA-RAdapt Integrated Health09/24/2025
Calvin Burch, PSS-YSAdapt Integrated Health10/13/2025
Chandra Faison, QMHP-RAdapt Integrated Health05/12/2025
Heather Robinson, PCAAdapt Integrated Health11/03/2025
Kimberly Smith, QMHP-RAdapt Integrated Health10/29/2025
Kayla Kelly, RNAdapt Integrated Health08/13/2024
Carolyn Starnes, RNAdapt Integrated Health04/07/2025
Cassidy Koehler, RNAdapt Integrated Health10/10/2025
Julie Bearup Wyatt, RNAdapt Integrated Health09/10/2025
Stephanie Bueckert CRMAdapt Integrated Health10/01/2025
Lynn Hill, PSS-AMH, PSS-AAAdapt Integrated Health10/13/2025
Ralph Morones, PSS-AA, PSS-MHAdapt Integrated Health10/13/2025
Obadiah Watkins, QMHA-RAdapt Integrated Health06/09/2025
James Wells, CRMAdapt Integrated Health12/09/2024
Holly Yellowhammer, QMHP-RAdapt Integrated Health12/16/2024
Kari Carey, RN, QMHP-RAdapt Integrated Health09/24/2025
Angela Christianson, PHARMPeaceHealth10/09/2025
Jodi Nelson, PHARMPeaceHealth06/10/2025
Jennifer Walker, PHARMPeaceHealth06/03/2025

On the Lookout

New Evidence on Vaping and Pregnancy Risks

Until recently, data on the effects of vaping during pregnancy—particularly the impact of nicotine-free e-liquids—was limited. A new murine study published in October 2025 offers important early evidence on potential developmental and neurocognitive harms.

The study examined in-utero exposure to e-cigarette vapor (both nicotine-containing and nicotine-free) and followed offspring from birth through early adulthood.

Key findings included:

  • Offspring exposed in utero to both nicotine and nicotine-free e-liquids demonstrated increased weight gain, memory impairment, and behavioral challenges.
  • Brain tissue analyses showed neuroinflammation, advanced cellular senescence, reduced SIRT1, and elevated beta-amyloid and NADPH oxidase 1—markers linked to oxidative stress and pathways associated with neurodegenerative disease.
  • Exposure to nicotine-free e-liquid alone produced significant effects, challenging assumptions that “nicotine-free” vaping is a safer alternative during pregnancy.
  • Device power and heat settings mattered: higher-power exposures (30 W) produced greater impairment compared with lower-power settings (5 W), suggesting that heating intensity may play a critical role in toxicity.

While this research was conducted in a murine model and cannot be directly generalized to humans, it adds to a growing body of evidence highlighting potential risks of vaping—nicotine-containing or not—during pregnancy.

As the authors conclude:
“We should not assume that vaping during pregnancy is either ‘safe’ or even ‘safer’ than smoking until we understand the long-term effects to both users and those indirectly exposed, such as in utero exposure during pregnancy.”

Read the full study:
Mills A, Corbin D, Dakhallah D, Chantler PD, Olfert IM. Nicotine influence on cerebrovascular and neurocognitive function with in utero electronic cigarette exposure. J Physiol. 2025. https://doi.org/10.1113/JP289175

Dental Digest

Top Causes of Vision Problems in Children

School-based vision screenings can help identify children who may have vision problems, but they do not provide a complete evaluation of eye health. Comprehensive eye exams with an optometrist are recommended to detect and address conditions early.

Read the full article on Advantage Dental

Health Care Interpreter Registry

Accurate and timely interpreter access is essential to delivering safe, equitable, and compliant care.

Forms & Handbook

Access PA forms, referrals, and provider policies all in one place.